|Legal Status||Not Controlled|
No legal implications
Selective serotonin re-uptake inhibitor (SSRI). Used for the treatment of major depression, bulimia nervosa and obsessive-compulsive disorder.
|Short Term Effects||
Central nervous system features include tremor, agitation, dizziness, fatigue, drowsiness, coma and convulsions. Nausea, vomiting, dilated pupils and sweating may occur. Cardiovascular features seen with SSRIs include tachycardia, hypotension, hypertension, prolongation of QT interval and QRS duration, Torsade de Pointes, and cardiac arrest.
Death has been reported after ingestion of 6-12 g (Compton et al, 2005; Kincaid et al, 1990)
Identified in Poland: • N-(2-(dimethylamino)cyclohexyl)-N-methylbenzo[d][1,3]dioxole-5-carboxamide (3,4-methylenedioxy-U-47700)a NPS Opioid
There have been recent deaths and hospitalisations relating to substance use at festivals.: Be aware that over the past few years there has been an increase in the dosage and purity of substances available, in particular MDMA ‘Ecstasy’ pills. Increased purity and dosage means an increase in potential for adverse effects. Pills and powders etc.. may not contain what is intended, different substances have different doses,effects, time of onset and duration. Where WEDINOS have tested pressed pills; the result relates only to the samples analysed and cannot be used to indicate the contents, profile or quality of a wider batch of the substance. This is always the case despite pills having the same logo, shape size and colour.